Keywords: Melanoma drug market, Pneumo- and meningococcal vaccines, GlobalData, Datamonitor, Pfizer, Prevnar

Melanoma drug market to see CAGR of 16.8% to reach $1.42 billion by 2017; pneumo- and meningococcal vaccines forecast

Article | 31 January 2011

Print This

The worldwide market for melanoma therapeutics was valued at $351 million in 2009 and is forecast to grow at a compound annual ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in